Frontlight ResearchEarly access
Trial site
Ankara Universitesi Tip Fakultesi Hastanesi
- 6running trials
- 4closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Prostate cancer3 trials
- Obesity2 trials
- Acute lymphoblastic leukaemia1 trial
- Acute myeloid leukaemia1 trial
- Bladder cancer1 trial
- Childhood cancers1 trial
- Chronic kidney disease1 trial
- Chronic lymphocytic leukaemia1 trial
- Chronic myeloid leukaemia1 trial
- Colorectal cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- and 5 more
- Phase
- Phase 37 trials
- Phase 42 trials
- Phase 11 trial
- Status
- Active, not recruiting5 trials
- Completed3 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Amgen3 trials
- Bayer3 trials
- Eli Lilly and Company3 trials
- Pharmacyclics Switzerland GmbH1 trial
Running trials
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
Closed trials
Completed
Completed
Terminated
Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026